A week after healthcare unicorn Ro landed capital from existing investors at a higher valuation, two top executives have parted ways with the company, per an internal email obtained by TechCrunch from multiple employees. In the e-mail, CEO and co-founder Zachariah Reitano said that COO George Koveos and GM of Ro Pharmacy Steve Buck are […]...
